Protagenic Therapeutics, Inc., upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Brian Corvese to the Board, with a term to expire at the company's 2018 annual meeting of stockholders. The appointment of Mr. Corvese was made to fill the vacancy on the Board created by the resignation of Gregory K. Ekizian effective as of June 20, 2017. The Board has determined that Mr. Corvese is an independent director" as defined in the Nasdaq Listing Rules. Mr. Corvese has been appointed to the company's Audit Committee, which he will chair, and to the Company's Compensation Committee. Mr. Corvese currently serves on the Board of Directors of the National Telecommunications Corporation, based in Cairo, Egypt.